-
-
Was reported by the Chinese explorer Zheng He
-
Jeramia - a colonial power on another continent
-
Therefore the pursuit of the Yak became less dangerous
-
-
it is a major component of R.'s success
-
Aurok - small, landlocked, least-developed country, population around 1.2 million
-
-
and other specialized agencies including the WHO
-
-
was spent on international linkages, development of research infrastructure, and incentives to government researchers and inventors
-
-
- CEO of DORTA
- R. Minister of IP (date)
-
-
-
-
private company DORTA M/S
-
-
He: 1.has been employed by DORTA
2. works in a DORTA-operated private hospital in R.
3. R.-licensed medical doctor and citizen of R. -
observed that the incidence of diabetes and obesity was lower among his A. patients than among his R. patients.
-
the discrepancy was correlated with a never-before-identified enzyme found in the gallbladder of the Yak, a key ingredient in Tirhinga Nos Lustuk.
-
Discovery of "the Lustuk Enzyme"
-
Gallvectra treats insulin resistance-related diseases
-
world-renowned expert in rural A.
-
concerned the creativity of DORTA's patent
-
A. people have never produced reliable drug
-
-
it has subsidiaries in over 50 countries (no in A.)
-
in countries that had approved it for prescription use
-
majority of A. population is rural, living in villages and settlements of fewer than 200 people
-
-
Carla Alexander reported that 2014 sales of the Gallvectra topped 2 billion Euro
-
-
A.Truth - nation's only daily newspaper
-
the Courier-Mail is Brisbane-based (Australia);
research on payment for gallbladder by DORTA -
1.bill to fund Yak research - emphasis on breeding methods for Yak in captivity;
2. 5-year moratorium on the Yak-female hunting of breeding age -
DORTA announced its own captive breeding program
-
"disruption of balance between the Yak and human population"
-
-
the departure of the Yak for the south
-
PM Sumun asked that DORTA ceased Yak harvest
-
attendee asked whether the company was concerned bout the sustainability of the herd
-
was released by the R. Ministry of Agriculture on all major digital platforms
-
anecdotal evidence
-
-
-
Gallvectra was added to the WHO List of Essential Medicines
-
prohibited export of Yak products, imposed sanctions on R. and R. companies for doing business in A.
-
-
requesting that the Kayleff Yak to be included in Appendix III of CITES
-
"fear of A. villagers that Yak will become extinct during their lifetime"
-
R. didn't communicate a reservation or an objection
-
the Yak was included in Appendix I of the CMS
-
PM Sumun presented her counterpart a demarche
-
-
-
-
-
ONLY to the registered agents of the company
-
contracts:
1. committed DORTA to pay for gallbladders upon delievery;
2. obligated the hunters to abide by all relevant R. laws;
3. capped DORTA;s annual harvest at 30.000 Yak
